| 讲座 |
|
|
|
|
| 组织工程产品的种类及应用——组织工程连载之六 |
| 王佃亮 |
| 第二炮兵总医院药学部组织工程与再生医学实验室 北京 100088 |
|
| Types and Applications of Tissue Engineering Products |
| WANG Dian-liang |
| Tissue Engineering and Regenerative Medicine Laboratory, The Second Artillery General Hospital, Beijing 100088, China |
|
[1] Pirnay J P, Vanderkelen A, De Vos D, et al. Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems. Cell Tissue Bank, 2013,14(4):525-560.
[2] Lewandowska-Szumiel M, Wójtowicz J. Bone tissue engineering - a field for new medicinal products? Curr Pharm Biotechnol, 2011,12(11):1850-1859.
[3] Berthiaume F, Maguire T J, Yarmush M L.Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng, 2011,2:403-430.
[4] Barai N D, Boyce S T, Hoath S B, et al.Improved barrier function observed in cultured skin substitutes developed under anchored conditions. Skin Res Technol, 2008,14(4):418-424.
[5] Pan Y, Chu T, Dong S, et al. Cells scaffold complex for Intervertebral disc Anulus Fibrosus tissue engineering: in vitro culture and product analysis. Mol Biol Rep, 2012,39(9):8581-8594.
[6] Zhou H Z, Yu H, Xue Y. In vivo self-expanding engineering of bone. Med Hypotheses, 2009,73(4):528-530.
[7] Inoue H. The present situation and future prospects of bone substitute of bioinspired materials.Clin Calcium, 2008, 18(12):1729-1736.
[8] Tedder M E, Simionescu A, Chen J, et al. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng Part A, 2011,17(1-2):25-36.
[9] Schmedlen R H, Elbjeirami W M, Gobin A S, et al. Tissue engineered small-diameter vascular grafts. Clin Plast Surg, 2003,30(4):507-517.
[10] Noishiki Y, Yamane Y, Okoshi T, et al. Choice, isolation, and preparation of cells for bioartificial vascular grafts. Artif Organs, 1998,22(1):50-62.
[11] Cho H J, Lee H J, Chung Y J, et al. Generation of human secondary cardiospheres as a potent cell processing strategy for cell-based cardiac repair. Biomaterials, 2013,34(3):651-661.
[12] Shazly T, Kolachalama V B, Ferdous J, et al.Assessment of material by-product fate from bioresorbable vascular scaffolds. Ann Biomed Eng, 2012,40(4):955-965.
[13] Daadi M M, Steinberg G K. Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy. Regen Med, 2009,4(2):251-263.
[14] Magin R L. Fractional calculus in bioengineering, part 3. Crit Rev Biomed Eng,2004,32(3-4):195-377.
[15] Yannas I V, Hill B J. Selection of biomaterials for peripheral nerve regeneration using data from the nerve chamber model. Biomaterials, 2004,25(9):1593-1600.
[16] Lenas P, Luyten F P, Doblare M, et al.Modularity in developmental biology and artificial organs: a missing concept in tissue engineering. Artif Organs, 2011, 35(6):656-662.
[17] Guthke R, Zeilinger K, Sickinger S, et al. Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors. Bioprocess Biosyst Eng, 2006,28(5):331-340.
[18] Kim H L, Lee J H, Lee M H, et al. Evaluation of electrospun (1,3)-(1,6)-β-D-glucans/biodegradable polymer as artificial skin for full-thickness wound healing. Tissue Eng Part A, 2012,18(21-22):2315-2322.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
